No changes in adolescent's sedentary behaviour across Europe between 2002 and 2017.

BACKGROUND: Public health organizations have been alerted to the high levels of sedentary behaviour (SB) among adolescents as well as to the health and social consequences of excess sedentary time. However, SB changes of the European Union (EU) adolescents over time have not been reported yet. This study aimed to identify SB of the EU adolescents (15-17 years) in four-time points (2002, 2005, 2013 and 2017) and to analyse the prevalence of SB according to the sex. METHODS: SB of 2542 adolescents (1335 boys and 1207 girls) as a whole sample and country-by-country was analysed in 2002, 2005, 2013, and 2017 using the Sport and Physical Activity EU Special Eurobarometers' data. SB was measured using the sitting time question from the short version of the International Physical Activity Questionnaire (IPAQ), such that 4h30min of daily sitting time was the delineating point to determine excess SB behaviour (≥4h30min of sitting time) or not (≤4h30min of sitting time). A χ2 test was used to compare the prevalence of SB between survey years. Furthermore, SB prevalence between sexes was analysed using a Z-Score test for two population proportions. RESULTS: The prevalence of SB among EU adolescents across each of the four survey years ranged from 74.2 and 76.8%, rates that are considered high. High levels of SB were also displayed by both sexes (girls: 76.8 to 81.2%; boys: 71.7 to 76.7%). No significant differences in the prevalence of SB among years (p > 0.05) were found for the whole sample, and for either girls or boys. Also, no significant differences in the prevalence of SB between girls and boys were found. CONCLUSION: The SB prevalence in European adolescents is extremely high (76.8% in 2017) with no differences between girls and boys. No significant improvements have been seen between 2002 and 2017. Eurobarometer should increase the adolescents' sample to make possible benchmarking comparisons among the EU countries and extend the survey to the younger children population.

Influence of body condition and bovine somatotropin on estrous behavior, reproductive performance, and concentrations of serum somatotropin and plasma fatty acids in postpartum Brahman-influenced cows.

Ninety-nine multiparous Brahman-influenced (1/4 to 3/8 Brahman) cows were managed to achieve low (BCS = 4.3 +/- 0.1; n = 50) or moderate (BCS = 6.1 +/- 0.1; n = 49) body condition (BC) to determine the influence of bovine somatotropin (bST) on estrous characteristics, reproductive performance, and concentrations of serum GH and plasma NEFA. Beginning 32 d postpartum, cows within each BC were assigned randomly to treatment with or without bST. Non-bST-treated cows received no treatment, and treated cows were administered bST (Posilac, 500 mg s.c.) on d -35, -21, and -7 before initiation of the breeding season. On d -7, all cows received an intravaginal, controlled internal drug-releasing (CIDR) device. On d 0 (initiation of the 70-d breeding season), the CIDR were removed and cows received prostaglandin F2alpha (PGF2alpha). Blood samples were collected from the median caudal vein of the cows at each bST treatment and at d -28 and 0. Estrous behavior was monitored by radiotelemetry during the first 30 d of the breeding season. Growth hormone was increased (P < 0.05) in low and moderate BC cows treated with bST. The percentage of cows detected in estrus during the first 30 d of the breeding season was decreased (P = 0.05) for low BC (64%) compared with moderate BC (82%) cows. The interval to first estrus tended (P = 0.07) to be shorter in low BC-bST-treated cows (3.7 +/- 1.9 d) than in moderate BC-bST-treated cows (9.6 +/- 1.8 d). During the first 30 d of the breeding season, cows in low BC had a decreased (P = 0.02) number of mounts received and increased (P = 0.001) quiescence between mounts compared with cows in moderate BC. The number of mounts received was reduced (P = 0.04) in bST-treated cows. More (P = 0.02) cows treated with bST became pregnant during the first 3 d of the breeding season compared with non-bST-treated cows. The cumulative first-service conception rate tended (P = 0.07) to be greater for bST-low BC cows than non-bST-treated cows in low or moderate BC. On d 0, NEFA were greater (P < 0.05) in bST-treated vs. non-bST-treated cows. Low BC and bST reduced the intensity of behavioral estrus in postpartum Brahman-influenced cows. However, bST increased the first-service conception rate during the first 30 d of breeding and pregnancy rates during the first 3 d of breeding in postpartum Brahman-influenced cows.

Concept analysis of relating: a human response pattern.

TOPIC: An investigation of relating, one of the nine human response patterns, used as the conceptual basis for the classification of nursing diagnoses. PURPOSE: A formal linguistic analysis of each of the nine human response patterns is warranted in order to allow a continuation of the exploration, definition, and development of research-based practice based on the NANDA framework. SOURCE: "Human Response Patterns" developed by NANDA, historical foundations of the concept of relating, the use of this construct by nursing and other disciplines. CONCLUSIONS: Concept analysis of relating resulted in conceptual and operational definitions. The efficacy of further developing nursing's taxonomic tree on the nine human response patterns has been advanced.

Effects of cancer on the sexuality and fertility of women.

As more Americans become cancer survivors, sexuality and fertility have become more paramount issues in cancer care. Both the disease and the treatments used can produce both short-term and long-term effects that can confound sexual expression and fertility. The identification of these sequelae in survivors of cancer has led to the exploration of methods to predict, prevent, or minimize their occurrence. This article addresses the effects of cancer and cancer care in those undergoing treatment and surviving the array of diseases known as cancer.

The sexual adaptation of women treated for endometrial cancer.

This study explores the process of sexual adaptation in women treated for endometrial cancer. Methodology was primarily qualitative with in-depth interviews. Data were collected by means of semistructured tape-recorded interviews; detailed field notes; and quantitative measures of self-concept, self-esteem, body image, and satisfaction with sexual functioning. The quantitative instruments used to measure these constructs were the Tennessee Self-Concept Scale and three visual analog scales. A vivid picture of women's experience of sexual adaptation after treatment for endometrial cancer emerged. This study's findings indicate that the experience of sexual adaptation in women who undergo treatment for endometrial cancer is a process that evolves. This process begins with the onset of symptoms and continues beyond the completion of therapy. Factors that enhanced the adaptational process were identified by the participants.

Standards for assay of von Willebrand factor concentrates: a collaborative study.

A multilaboratory collaborative study was undertaken to assess the feasibility of using a plasma standard for expressing the results of assays for the von Willebrand factor content of von Willebrand factor concentrates and of factor VIII concentrates. Thirteen laboratories tested six concentrates for von Willebrand factor antigen, ristocetin cofactor activity, and multimer content using the World Health Organization plasma standard for factor VIII/von Willebrand factor, 87/718, as a standard. Only a few assays were invalid because of nonparallelism or nonlinearity. Significant interlaboratory and interassay differences were found for both von Willebrand factor antigen and ristocetin cofactor activity. There was generally good agreement between the laboratories with respect to the multimer content in the preparations. With respect to assay validity, a plasma standard could be suitable for assaying concentrated preparations of von Willebrand factor.

Evaluation of mating systems involving five breeds for integrated beef production systems: IV. Accounting for variability and genetic trends.

Computer models were used to simulate integrated cow-calf-feedlot production systems. Angus (A), Charolais (C), Hereford (H), Limousin (L), and Simmental (S) purebreds and two- and three-breed rotational crossbreds were included. Models were deterministic and based on data reported primarily from the 1970s. Variation in carcass weights were determined to predict distributions of carcass weights and values for 272- to 318-kg carcasses. Data were updated to a 1984 base by increasing birth, weaning, yearling, and mature weights to account for genetic trends within breeds. Two slaughter end points were considered: 288-kg carcass weight and low Choice grade. At low Choice grade, accounting for variation in carcass weights around the 272- to 318-kg target weight increased the estimated efficiency of A and AH crosses (input costs/carcass value), whereas at the 288-kg end point, efficiency rankings among other breed combinations were relatively unchanged. Including genetic trends resulted in increased estimated efficiencies among breed combinations with previously underweight carcasses at low Choice (A and AH), measured either as input costs/carcass weight or lean weight values. Within breeds, accounting for genetic trends and variation for weights caused breeds to be ranked differently when evaluated at low Choice.

Viral safety of clotting factor concentrates.

The efforts to reduce the risk of viral disease due to clotting factor concentrates have been quite successful. However, additional steps need to be taken to protect the users of these products. First, all patients should be vaccinated against hepatitis B. Second, vaccines against other viruses need to be developed. There is a great deal of interest in an HIV vaccine, and a vaccine against hepatitis C would also be a great boon to the "at risk" population. Third, more effective inactivation procedures need to be implemented in the manufacturing of concentrates other than Factor VIII, including Factor IX Complex, Coagulation Factor IX (Human), and Anti-Inhibitor Coagulant Complex. Despite the advances that have been made, it should be remembered that none of these procedures is perfect and the risk will never be reduced to zero. This is because the plasma pools will always contain infectious virus and the manufacturing process, regardless of how carefully controlled, cannot be made fail-safe. Errors will be made that result in contamination or inadequate treatment of products. For this reason, strict adherence to standard operating procedures and good manufacturing practices is essential. The investments of time, money, and hard work that have been made toward improving the safety of clotting factor concentrates have yielded a handsome return thus far. It is hoped that continued efforts in this direction will result in even greater benefits.

Evaluation of mating systems involving five breeds for integrated beef production systems: I. Cow-calf segment.

Deterministic computer models were used to simulate the cow-calf segment of an integrated production system. Angus, Charolais, Hereford, Limousin, and Simmental breeds were included in three mating systems: pure-breeding (PB) or two- (2R) or three-breed (3R) rotational crossbreeding. Breed data were taken from the literature. Herds were evaluated over the production year. Sires represented breed averages and were available from sources outside their herds, and 100 replacement heifers were saved annually. Females in 3R had the highest average energy requirements (8,144 Mcal of ME.cow-1.yr-1) and production costs ($322.31.cow-1.yr-1), and PB females had the lowest average requirements (7,748 Mcal of ME.cow-1.yr-1) and costs ($313.2.cow-1.yr-1). Purebred systems were the least biologically and economically efficient (64.9 Mcal of ME/kg of steer equivalent, $2.35/kg of steer equivalent), respectively, and 3R systems were the most efficient (56.6 Mcal of ME/kg of steer equivalent, $1.95/kg of steer equivalent). On average, 3R systems were more efficient biologically and economically than 2R systems. However, some 2R systems were as efficient as some 3R systems. Crossbred combinations containing Angus and(or) Hereford ranked more biologically and economically efficient than other breed combinations. Conversely, British purebreds ranked more biologically efficient, whereas Continental purebreds ranked more economically efficient.

Evaluation of mating systems involving five breeds for integrated beef production systems: II. Feedlot segment.

Computer models were used to simulate the feedlot segment of an integrated beef production system. Five breeds, Angus (A), Charolais (C), Hereford (H), Limousin (L), and Simmental (S), in three mating systems, pure-breeding and two- and three-breed rotational crossbreeding, were evaluated for feedlot and carcass performance. Breed data were taken from the literature. Feeder calves (steers and non-replacement heifers) entered the feedlot at 205 d of age. After a 35-d adjustment period, calves were custom-fed to four slaughter end points: 440 d, 457 d, 288-kg carcass weight, or low Choice. Cattle were fed to requirements (megacalories of ME). Input costs included feed and nonfeed expenses (purchase prices, transportation, yardage, and medicinal fees). Carcass values were $2.65 and $2.54/kg of carcass weight for steer and heifers, respectively, between 272 to 318 kg. Over- or underweight carcasses were discounted $.60/kg. At the 440-d end point, Select grade steer and heifer carcasses were discounted an additional $.22 and $17/kg, respectively. Biological efficiency was measured as megacalories of ME/kg of gain, and economic efficiencies were measured as input costs per kilogram of carcass weight, input costs per kilogram of lean weight, and input costs per carcass value. Continental breed combinations (C and S) were most efficient at age- and weight-constant end points for megacalories of ME per kilogram of gain and for input costs per carcass value and most efficient at all end points for input costs per kilogram of carcass weight and input costs per kilogram of lean weight. British breed combinations (A) were most efficient at a fat-constant end point for megacalories of ME per kilogram of gain and input costs per carcass value. Therefore, choosing breed combinations for feedlots depends on slaughter end point and measures of efficiency.

Evaluation of mating systems involving five breeds for integrated beef production systems: III. Integrated system.

Angus (A), Charolais (C), Hereford (H), Limousin (L), and Simmental (S) breeds were included in deterministic computer models simulating integrated cow-calf-feedlot production systems. Three mating systems were used: pure-breeding and two-and three-breed rotational crossbreeding. Breed information was taken from the literature. Herd sizes were unrestricted; however, 100 heifers were saved as replacements. Cows were removed for reproductive failure, age (greater than 10.5 yr), or death. Calves produced in the cow-calf segment were fed in a custom feedlot to four slaughter end points: 440 d, 457 d, 288-kg carcass weight, and low Choice. All animals were fed to requirements. Cull cows were slaughtered after weaning. Biological and economic efficiencies improved with crossbreeding; however, rankings of breed combinations depended on how efficiencies were measured (weight, lean, or value basis). Among purebreds, reproductive performance had a large influence on breed rankings at age and weight end points, whereas feedlot performance was important at the low Choice end point. Crossbred combinations involving British (A or H) and Continental (C or S) breeds were more efficient than other crossbred combinations at all end points. However, choosing specific breed combinations for integrated systems depends on slaughter end points, market end points (weight vs lean), and measures of efficiency (weight, lean, or value basis).

Standardization of factor IX: standards for "purified" factor IX concentrates.

An international collaborative study was carried out to determine the suitability of the current WHO II-IX-X concentrate standard, 84/681, for assigning potency to the more highly purified factor IX concentrates. Three Coagulation Factor IX (Human) preparations and one Factor IX Complex preparation were assayed by the one stage method against WHO 84/681 following predilution to 1.0 u/ml in buffer, 1% albumin, or factor IX deficient plasma. There were no cases of non-parallelism between any of the preparations and the current WHO standard. Predilution of the Coagulation Factor IX (Human) preparations in 1% albumin or factor IX deficient plasma gave similar potency values. Predilution in buffer gave significantly lower (p less than 0.01) potency values. For the Factor IX Complex preparation, potency estimates were significantly different (p less than 0.01) with each prediluent. The overall precision was similar within each predilution for all preparations with predilution in buffer being less precise than predilution in albumin or in deficient plasma. WHO standard 84/681 appears to be a suitable standard for the potency determination of the more highly purified factor IX preparations. Predilution in 1% albumin or factor IX deficient plasma is recommended as they give equivalent results with the least variability.

Psychosexual issues: the woman with gynecologic cancer.

Psychosexual concerns often confront women with a diagnosis of gynecologic cancer. These concerns can be physiologic or psychological in origin. Oncology nurses are in a key position to assess these potential or actual sexual problems. Interventions can be designed to prevent or minimize the adverse sexual sequelae often associated with this group of diseases. A strong knowledge base and comfort with the topic of sexuality are of utmost importance.

Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor.

Botrocetin (venom coagglutinin) induces binding of von Willebrand factor (vWF) to platelet glycoprotein Ib (GPIb), resulting in platelet agglutination. A mechanism whereby botrocetin causes vWF to change to an active platelet-agglutinating form is proposed. Incubation of native vWF with botrocetin yielded an increasingly active vWF with slower migration in two-dimensional immunoelectrophoresis but with no apparent change in vWF multimer pattern. The "activated" vWF eluted mainly in the void volume (Vo) (Bio-Gel A-15m column chromatography). Botrocetin eluted in the included volume (Vi). Vo peaks appeared to contain a vWF-botrocetin complex, based on bioassays and immunoassays. 125I-Botrocetin mixed with vWF eluted in two peaks: in the Vo, coincident with active vWF, and in the Vi. With von Willebrand disease (vWD) plasma lacking vWF, 125I-Botrocetin eluted in the Vi only. It did not bind to platelets without vWF. In aggregometric studies, antibodies (Ab) against botrocetin, vWF, and GPIb prevented botrocetin-induced platelet agglutination and caused dissolution of preformed platelet agglutinates. Immunostaining of aggregates with antibotrocetin Ab revealed a positive reaction. Botrocetin appears to act in a two-step manner, first binding with vWF to form a complex, which then binds to GPIb to cause agglutination. All three components, vWF, botrocetin, and GPIb, appear to be required for maintenance of stable platelet agglutinates.

Evaluation of crossbreeding systems for small beef herds: II. Two-sire systems.

Stochastic computer models were used to evaluate nine crossbreeding systems in beef herds consisting of two bulls, 50 cows and 15 replacements. Systems examined were: 1) purebred (PB), 2) two- and three-breed rotations using natural service (2R and 3R) or artificial insemination (2RAI and 3RAI), 3) two-breed roto-terminals not exploiting complementarity using natural service (2RT) or AI (2RTAI) and 4) two-breed roto-terminals exploiting complementarity using natural service (2RTC) or AI (2RTCAI). Average heterosis estimates were taken from literature sources. Replacement females were produced within the herd; sires were purchased. Estimates of calf and dam heterosis were used to calculate performance of calf weight weaned and sold, cow and total weights sold and gross calf, cow and total incomes. All crossbred systems were superior to PB for weights sold and income. The natural-service systems (2R, 3R, 2RT and 2RTC) utilized 90 to 98% of the heterosis available in their AI counterparts (2RAI, 3RAI, 2RTAI and 2RTCAI). No differences were found between corresponding natural-service and AI systems for weights sold and incomes. Increasing the complexity of the system did not provide important improvements in traits measured.

Invasive cancer of the vulva. Diagnosis, surgical management, and nursing care.

Postoperatively, vulvar cancer patients visit the physician's office frequently until the incision is healed completely. Follow-up visits are then continued biannually and eventually annually. Postoperative mortality is directly related to the extensiveness of the disease at the time of diagnosis. If the lymph nodes are negative at the time of surgery, the five-year survival rate approaches 90%; however, if lymph nodes are positive, the five-year survival rate drops to about 33%. Because most women diagnosed with invasive cancer of the vulva are elderly, many die of noncancer related diseases while tumor free. Recurrence, if it should occur, may be distant or local. Local recurrence usually occurs at the margins of the resection and distant recurrence in the deep pelvic nodes. The radical vulvectomy procedure with bilateral groin node dissection poses a significant challenge to the perioperative nursing team. This team plays an important role in helping the patient and her partner adjust to this extensive procedure.

Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

A murine monoclonal antibody (mAb) against porcine von Willebrand factor (vWF) induced an antithrombotic state in normal pigs. Thrombosis was induced by a standard procedure of stenosis and mechanical injury of the artery. The mAb was an IgG1 kappa that inhibited vWF-induced platelet aggregation at a titer of 1:6250 and bound to immobilized vWF at a maximal dilution of 1:512,000. The antibody did not affect two other vWF functions, platelet adhesion and binding of coagulant factor VIII (factor VIII:C). The antithrombotic state was characterized by a prolonged bleeding time and lack of plasma vWF activity, but with near-normal levels of factor VIII:C and von Willebrand antigen. The circulating Ag.mAb complex demonstrated a multimeric distribution comparable to that of native plasma vWF. Three groups of pigs were studied: group A consisted of nine untreated animals, eight of which developed occlusive coronary thrombosis; group B, four treated animals with a long bleeding time, none of which developed occlusive thrombosis; and group C, two animals with preexisting thrombosis treated with mAb, in which stable blood flow was reestablished. Morphologically, the group B animals showed adherent platelets covering the injured intima but no thrombosis. This mAb is an antithrombotic agent that prevents platelet thrombosis without affecting intrinsic platelet function.

Myocardial infarction during pregnancy: a team challenge.

Myocardial infarction during pregnancy is rare but may be increasing in frequency because of the trend toward later childbearing and an overall increase in risk factors for women (smoking, high-stress careers). The physiologic changes and stresses of pregnancy and labor provide a unique and often devastating setting for coronary diseases. The mortality rate is extremely high, approaching 40% if delivery ensues within 2 weeks of infarction. A planned, induced labor with regional anesthesia and continuous invasive monitoring in a well-equipped medical center provides the safest setting for delivery. Assisted vaginal delivery may offer a lower risk of death than cesarean section. The nurse, as well as the other members of the multidisciplinary team, should be well versed in the normal physiologic stresses of pregnancy. The fetal and cardiac effects of all medications and interventions must be explored. The almost simultaneous appearance of a new child in one's life with a heightened and immediate awareness of one's own mortality can lead to overwhelming feelings of despair and anxiety. Transition to home life may be difficult. All aspects of the patient's needs from heart to hope, should be addressed.